Aquestive Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 34234000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2021-06-30) |
| Status | current |
| Entity | Aquestive Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:35:21.415897+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8ce2dc81-6f0f-4d66-a09a-111fa3149f9d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-21-015392Retrieved: 2026-08-19T13:35:21.415897+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001398733/cash-and-equivalents/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8ce2dc81-6f0f-4d66-a09a-111fa3149f9d
History
- no predecessors — first report